The largest database of trusted experimental protocols

Neurology 4 plex e

Manufactured by Quanterix
Sourced in United States

The Neurology 4-Plex E is a multiplex assay designed for the quantitative measurement of four biomarkers associated with neurological conditions. The core function of this product is to enable the simultaneous detection and quantification of these specified biomarkers in a single sample.

Automatically generated - may contain errors

4 protocols using neurology 4 plex e

1

Biomarker Quantification Using Simoa Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biomarker quantification was conducted using single molecule array (Simoa) HD‐X Analyzers from Quanterix at the Clinical Neurochemistry Laboratory of Sahlgrenska University Hospital in Sweden. A commercially available assay (Quanterix Neurology‐4 Plex E) was used to simultaneously quantify for Aβ42, Aβ40 (and Aβ42/Aβ40, consequently), NfL, and GFAP.
27 (link) P‐tau231 and p‐tau181 were analyzed using Simoa assays developed at the University of Gothenburg, which have been validated as described elsewhere.
5 (link),
6 (link) To measure p‐tau217, a novel commercially available assay from ALZpath (ALZpathDX) was used.
43 (link) All samples from the same participant were analyzed in the same analytical run, and each sample was quantified in duplicate. Internal quality controls (iQC) at three different concentrations, for each measurand, were analyzed in duplicate in the beginning and end of each run. Before analysis, blood samples were thawed, vortexed, and centrifuged at 4000 × g for 10 minutes as suggested in recent studies.
44 (link),
45 (link)
+ Open protocol
+ Expand
2

Plasma Biomarker Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma analysis was performed on the HD‐X Analyzer (Quanterix). Plasma p‐tau181 and p‐tau231 concentrations were measured using in‐house assays developed by the University of Gothenburg.8, 10 Plasma Aβ42, Aβ40, GFAP, and NfL were measured using commercially available immunoassay from Quanterix (Neurology 4‐Plex E).
+ Open protocol
+ Expand
3

Sensitive Measurement of Aβ Peptides in nEVs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Our pre-experiment results suggested that the electrochemiluminescence method was not sufficiently sensitive to detect Aβ and t-tau in nEVs (K15199E and K15121D, respectively; MSD; data not shown). Therefore, we used two single-molecule array kits (Simoa; Quanterix, Billerica, MA, USA): Neurology 4-Plex E and pTau-181 V2, to measure nEV proteins. Notably, compared to previous single-factor or tri-factor kits, the former was newly developed for highly specific and sensitive measurement of the concentrations of full-length Aβ1–42 and Aβ1–40 [27 (link)]. All assays were conducted in duplicate, and the quality control is described in Additional file 1: Supplementary material and shown in Additional file 1: Table S2. Unexpectedly, based on quality control, p-tau181 and neurofilament light (NFL) results were both excluded, and only Aβ40 and Aβ42 results were included in the subsequent analysis. We did not analyze glial fibrillary acidic protein, as this is an astrocytic marker.
+ Open protocol
+ Expand
4

Plasma Biomarkers for Neurodegeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
40, Aβ42, glial fibrillary acidic protein (GFAP), Nf-L, and P-Tau181 were measured in EDTA plasma using the respective commercially available kits; Neurology 4-Plex E and P-Tau181 (Quanterix©, Billerica, MA, USA) by Single Molecule Array (SIMOA®) HD-X Analyzer. The analyses were performed according to the manufacturer’s instructions. In addition, the manufacturer’s commercial controls were applied for quality control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!